Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Benner

Showing results (201-210 of 347) with videos related to

Pageof 35
Sort By:
Epigenomics|November 23, 2019
DNA methylation profiling to explore colorectal tumor differences according to menopausal hormone therapy use in womenSonja Neumeyer, Odilia Popanda, Katja Butterbach, et al.
Blood|March 15, 1995
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasHartmut Döhner, Konstanze Fischer, Martin Bentz, et al.
Genes, Chromosomes & Cancer|June 27, 2007
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomasStefan Pfister, Marc Remke, Grischa Toedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancerOlaf Thuerigen, Andreas Schneeweiss, Grischa Toedt, et al.
European Urology Open Science|July 23, 2025
Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP StudyMartin Wallisch, Peter Albers, Nikolaus Becker, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.
Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.
Blood|July 5, 2003
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeDirk Kienle, Alexander Kröber, Tiemo Katzenberger, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Pageof 35

Showing results (201-210 of 347) with videos related to

Sort By:
Pageof 35
Epigenomics|November 23, 2019
DNA methylation profiling to explore colorectal tumor differences according to menopausal hormone therapy use in womenSonja Neumeyer, Odilia Popanda, Katja Butterbach, et al.
Blood|March 15, 1995
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemiasHartmut Döhner, Konstanze Fischer, Martin Bentz, et al.
Genes, Chromosomes & Cancer|June 27, 2007
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomasStefan Pfister, Marc Remke, Grischa Toedt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2006
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancerOlaf Thuerigen, Andreas Schneeweiss, Grischa Toedt, et al.
European Urology Open Science|July 23, 2025
Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP StudyMartin Wallisch, Peter Albers, Nikolaus Becker, et al.
Plos One|September 22, 2017
Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic diseaseNina Wagener, Dominic Edelmann, Axel Benner, et al.
British Journal of Haematology|August 3, 2021
Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis: results from a large cohort of patients with long follow-upMarco Basset, Christoph R Kimmich, Nicholas Schreck, et al.
Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.
Blood|July 5, 2003
VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcomeDirk Kienle, Alexander Kröber, Tiemo Katzenberger, et al.
Haematologica|March 28, 2008
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlationsSandrine Sander, Lars Bullinger, Elke Leupolt, et al.
Pageof 35